Holding(s) in Company

RNS Number : 0767S
Advanced Medical Solutions Grp PLC
02 September 2010
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

ADVANCED MEDICAL SOLUTIONS GROUP

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights


X

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


 

An event changing the breakdown of voting rights


 

Other (please specify):

 


 

3. Full name of person(s) subject to the notification obligation:

 

AXA S.A. 25 Avenue Matignon, 75008 Paris and its group of companies

4. Full name of shareholder(s) (if different from 3.):

 


5. Date of the transaction and date on which the threshold is crossed or reached:

 


01/09/2010

6. Date on which issuer notified:

 

02/09/2010

7. Threshold(s) that is/are crossed or reached:

 

10%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect


15,688,602

15,688,602

300,000

300,000

14,388,602

0.20

9.38

453659

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Expiration
date

Exercise/
Conversion
Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise
price

Expiration
date

Exercise/
Conversion
period

Number of voting
rights instrument
refers to

% of voting rights

 






Nominal

Delta

 



 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights


14,688,602


9.58%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 

Name of the Company/Fund Number of Shares % of Issued 
share capital
AXA France
Indirect
500,000.00 0.325995
AXA IM UK
Direct
300,000.00 0.195597
AXA IM UK
Indirect
13,888,602.00 9.055233

Total Direct
Total Indirect

300,000
14,388,602
0.19560
9.38123
TOTAL 14,688,602 9.57683

 

Proxy Voting:

 

10. Name of the proxy holder:

 


11. Number of voting rights proxy holder will cease to hold:

 


12. Date on which proxy holder will cease to hold voting rights:

 


 

13. Additional information:

 


14. Contact name:

 

Charles Tissier

15. Contact telephone number:

 

020 7003 1510

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUURSRRAAKRAR
UK 100